Linz, Australia

Franz Rovenszky

This inventor holds 1 USPTO granted patent. Top assignee: Hafslund Nycomed Pharma Aktiengesellschaft. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Franz Rovenszky. Retrieved from https://idiyas.com/inventor/franz-rovenszky-u8shfo6f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Franz Rovenszky: Innovator in Amino Acid Derivatives

Introduction

Franz Rovenszky is a notable inventor based in Linz, Austria. He has made significant contributions to the field of chemistry, particularly in the development of novel compounds. His work focuses on asymmetrically substituted diaminodicarboxylic acid derivatives, which have potential applications in various industries.

Latest Patents

Franz Rovenszky holds 1 patent for his invention titled "Asymmetrically substituted diaminodicarboxylic acid derivatives." This patent relates to innovative compounds that could enhance the efficacy of certain chemical processes and products.

Career Highlights

Rovenszky is associated with Hafslund Nycomed Pharma Aktiengesellschaft, a company known for its advancements in pharmaceuticals. His role at the company has allowed him to explore and develop new chemical entities that contribute to the pharmaceutical landscape.

Collaborations

Franz Rovenszky collaborates with Johann Hiebl, who is also involved in the research and development of innovative chemical compounds. Their partnership exemplifies the importance of teamwork in advancing scientific research.

Conclusion

Franz Rovenszky's contributions to the field of chemistry through his patent on diaminodicarboxylic acid derivatives highlight his innovative spirit and dedication to scientific advancement. His work continues to influence the pharmaceutical industry and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…